Plain-English translation of NCT07169630 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This research study is looking for signs of brain inflammation in people with memory loss or Alzheimer's disease. Researchers will use special imaging scans (PET and MRI) to take pictures of your brain and look for a protein called PDE4B, which may indicate inflammation. The study compares findings in people with memory problems to healthy volunteers without memory issues.
Doctors believe that brain inflammation may play a role in memory loss and Alzheimer's disease, but they don't yet have a good way to detect it in living patients. This study aims to develop imaging techniques that could one day help identify inflammation early, potentially leading to better treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the NIH for testing appointments where you'll have two special brain imaging scans (a PET scan and an MRI scan) and one standard MRI scan of your brain. You'll also have blood drawn to measure certain proteins, and you'll complete memory and thinking tests. The study is designed as a one-time or short-term evaluation; the exact duration and number of visits will depend on the specific study schedule.
AI-generated summary from trial data ยท Aug 22, 2026 ยท Not medical advice
United States